Market Overview 2022-2027:
The global biosensors market reached a value of US$ 24.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 39.9 Billion by 2027, exhibiting a CAGR of 8.51% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A biosensor, or biological sensor, is an analytical device used to detect changes in various biological processes and convert them into an electrical signal. It is used for monitoring biological elements, such as enzymes, nucleic acids, tissues, cell receptors, microorganisms and antibodies. Some of the commonly used biosensors include mass, optical, electrochemical, magnetic, nanomechanical, thermometric, acoustic and immunosensors. They consist of a responsive sensor, transducer, microcontroller, signal conditioning circuit and display unit and are embedded in resonant mirrors, chemical canaries, optodes, bio-computers, biochips and glucometers. Biosensors are extensively used for point-of-care (POC) diagnostics, research, environmental monitoring and biodefense applications.
Biosensors Market Trends:
Significant growth in the medical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, widespread adoption of wearable biosensors for continuous monitoring of vital signs of patients, infants, children, athletes and fitness enthusiasts is providing a thrust to the market growth. These biosensors facilitate remote monitoring of the individuals and can transmit biological data to the physician for real-time alerts. They are also incorporated in smart textiles for convenient tracking of vital signs. In line with this, as the coronavirus disease (COVID-19) continues to spread, there has been a substantial increase in the demand for biosensors in the healthcare centers for continuous monitoring of the patients. Additionally, various technological advancements, such as the integration of connected devices with the Internet of Things (IoT) and the development of innovative nanotechnology-based biosensors, are acting as other growth-inducing factors. These biosensors are used in nanotubes, nanowires, nanorods and nanoparticles for biomolecular detection. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biosensors market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology, application and end use.
Breakup by Product:
- Wearable Biosensors
- Non-Wearable Biosensors
Breakup by Technology:
- Electrochemical Biosensors
- Optical Biosensors
- Piezoelectric Biosensors
- Thermal Biosensors
- Nanomechanical Biosensors
- Others
Breakup by Application:
- Blood Glucose Testing
- Cholesterol Testing
- Blood Gas Analysis
- Pregnancy Testing
- Drug Discovery
- Infectious Disease Testing
- Others
Breakup by End Use:
- Point of Care Testing
- Home Healthcare Diagnostics
- Research Laboratories
- Security and Biodefense
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AgaMatrix Inc. (WaveForm Technologies Inc), DuPont de Nemours Inc., F. Hoffmann-La Roche AG, General Electric Company, LifeScan Inc. (Platinum Equity LLC), Medtronic PLC, Nova Biomedical Corporation, PHC Holdings Corporation, Siemens AG and Thermo Fisher Scientific Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2021 |
Historical Period |
2016-2021 |
Forecast Period |
2022-2027 |
Units |
US$ Billion |
Segment Coverage |
Product, Technology, Application, End Use, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Abbott Laboratories, AgaMatrix Inc. (WaveForm Technologies Inc), DuPont de Nemours Inc., F. Hoffmann-La Roche AG, General Electric Company, LifeScan Inc. (Platinum Equity LLC), Medtronic PLC, Nova Biomedical Corporation, PHC Holdings Corporation, Siemens AG and Thermo Fisher Scientific Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |